Adipokines in non-alcoholic fatty liver disease: are we on the road toward new biomarkers and therapeutic targets?

HIGHLIGHTS

  • who: Vera Francisco and collaborators from the Institute of Health Research INCLIVA, AvMenéndez Pelayo, Valencia, Spain Endocrinology and Nutrition Service, University Clinic Hospital of Valencia, AvBlasco Ibañez , have published the Article: Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?, in the Journal: (JOURNAL)
  • what: After the proof about the influence of ghrelin on insulin sensitivity, some research focused on ghrelin's role in NAFLD, but the evidence is scarce, and not all studies take into consideration the concentrations of total ghrelin and its . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?